In addition to PDEs, the levels of cAMP and cGMP are also regulated by the activities of multidrug resistance-associated proteins (MRPs) [16], and exposure to MRP inhibitors was shown to sensitise glioblastoma cells to chemotherapeutic drugs [17,18,19,20]. This evidence concerns the gene ABCC1 and glioblastoma.